NDTP
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Jul 21 closing price
Capitalization
9.76M
NGENF
Price
$2.58
Change
-$0.12 (-4.44%)
Updated
Jul 25 closing price
Capitalization
187.72M
Interact to see
Advertisement

NDTP vs NGENF

Header iconNDTP vs NGENF Comparison
Open Charts NDTP vs NGENFBanner chart's image
NDT Pharmaceuticals
Price$0.06
Change+$0.01 (+20.00%)
Volume$12.53K
Capitalization9.76M
NervGen Pharma
Price$2.58
Change-$0.12 (-4.44%)
Volume$100.37K
Capitalization187.72M
NDTP vs NGENF Comparison Chart in %
Loading...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGENF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NDTP vs. NGENF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDTP is a Hold and NGENF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (NDTP: $0.06 vs. NGENF: $2.58)
Brand notoriety: NDTP and NGENF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NDTP: 219% vs. NGENF: 40%
Market capitalization -- NDTP: $9.76M vs. NGENF: $187.72M
NDTP [@Biotechnology] is valued at $9.76M. NGENF’s [@Biotechnology] market capitalization is $187.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NDTP’s FA Score shows that 1 FA rating(s) are green whileNGENF’s FA Score has 0 green FA rating(s).

  • NDTP’s FA Score: 1 green, 4 red.
  • NGENF’s FA Score: 0 green, 5 red.
According to our system of comparison, both NDTP and NGENF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NDTP’s TA Score shows that 2 TA indicator(s) are bullish while NGENF’s TA Score has 2 bullish TA indicator(s).

  • NDTP’s TA Score: 2 bullish, 5 bearish.
  • NGENF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, NDTP is a better buy in the short-term than NGENF.

Price Growth

NDTP (@Biotechnology) experienced а +17.31% price change this week, while NGENF (@Biotechnology) price change was -6.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGENF($188M) has a higher market cap than NDTP($9.76M). NGENF YTD gains are higher at: 18.349 vs. NDTP (15.094).
NDTPNGENFNDTP / NGENF
Capitalization9.76M188M5%
EBITDAN/A-25.94M-
Gain YTD15.09418.34982%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A14.6M-
Total DebtN/A81.8K-
FUNDAMENTALS RATINGS
NDTP vs NGENF: Fundamental Ratings
NDTP
NGENF
OUTLOOK RATING
1..100
4956
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
96
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9747
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NDTP's Valuation (5) in the null industry is significantly better than the same rating for NGENF (96). This means that NDTP’s stock grew significantly faster than NGENF’s over the last 12 months.

NGENF's Profit vs Risk Rating (70) in the null industry is in the same range as NDTP (100). This means that NGENF’s stock grew similarly to NDTP’s over the last 12 months.

NGENF's SMR Rating (100) in the null industry is in the same range as NDTP (100). This means that NGENF’s stock grew similarly to NDTP’s over the last 12 months.

NGENF's Price Growth Rating (47) in the null industry is somewhat better than the same rating for NDTP (97). This means that NGENF’s stock grew somewhat faster than NDTP’s over the last 12 months.

NGENF's P/E Growth Rating (100) in the null industry is in the same range as NDTP (100). This means that NGENF’s stock grew similarly to NDTP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NDTPNGENF
RSI
ODDS (%)
Bearish Trend 2 days ago
29%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGENF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LFGSX40.100.32
+0.80%
Lord Abbett Focused Growth R4
CCQYX15.870.06
+0.38%
Columbia Disciplined Core Inst3
AWAAX23.750.04
+0.17%
AB Wealth Appreciation Strategy A
LAFGX16.350.02
+0.12%
Lord Abbett International Growth F
PWETX15.75-0.11
-0.69%
PACE International Em Mkts Eq P2

NDTP and

Correlation & Price change

A.I.dvisor tells us that NDTP and MAIA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDTP and MAIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDTP
1D Price
Change %
NDTP100%
N/A
MAIA - NDTP
21%
Poorly correlated
-0.58%
MMIRF - NDTP
11%
Poorly correlated
N/A
MBXBF - NDTP
7%
Poorly correlated
N/A
NGENF - NDTP
6%
Poorly correlated
-4.44%
MEOBF - NDTP
4%
Poorly correlated
N/A
More

NGENF and

Correlation & Price change

A.I.dvisor tells us that NGENF and CYTK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NGENF and CYTK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGENF
1D Price
Change %
NGENF100%
-4.44%
CYTK - NGENF
25%
Poorly correlated
-0.35%
IBRX - NGENF
23%
Poorly correlated
-4.98%
TNFA - NGENF
22%
Poorly correlated
-11.52%
CARM - NGENF
22%
Poorly correlated
-1.62%
ATRA - NGENF
22%
Poorly correlated
N/A
More